Biofrontera (BFRIW) Change in Account Payables (2024 - 2025)

Biofrontera (BFRIW) recorded quarterly Change in Account Payables of $3.4 million in Q4 2025, up 155.02% quarter-over-quarter from $1.3 million in Q3 2025, and up 2062.57% on a YoY basis from $155185.5 in Q4 2024.

Biofrontera (BFRIW) Change in Account Payables (2024 - 2025) Analysis & Trends

Biofrontera's Change in Account Payables history runs 2 years deep, the most recent figure standing at $3.4 million for Q4 2025.

  • In Q4 2025, Change in Account Payables rose 2062.57% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at -$2000.0 (up 99.86% YoY), while the FY2025 annual figure was -$2000.0, up 99.86% from the prior year.
  • Change in Account Payables was $3.4 million for Q4 2025 at Biofrontera, up from $1.3 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.4 million in Q4 2025 to a low of -$6.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 62.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 167.64 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 190,000.00
10 Biofrontera - - 14.09 Mn 3.36 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.36 Mn
Dec 31, 2025 3.36 Mn
Sep 30, 2025 1.32 Mn
Sep 30, 2025 1.32 Mn
Jun 30, 2025 -6.12 Mn
Jun 30, 2025 -6.12 Mn
Mar 31, 2025 1.44 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 -171,000.00
Dec 31, 2024 -171,000.00
Sep 30, 2024 2.16 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 -2.85 Mn
Jun 30, 2024 -2.85 Mn
Mar 31, 2024 -590,000.00
Mar 31, 2024 -590,000.00